Maturana-Ramiìrez A, Aitken-Saavedra J, Rojas-Zúñiga G, Rojas-Alcayaga G, Espinoza-Santander I, Rebolledo A, et al. Hypovitaminosis D in patients with oral squamous cell carcinoma: Is a risk factor of developing this neoplasia?. Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30 (1):e24-30.
doi0.4317/medoral.26692
https://dx.doi.org/doi:10.4317/medoral.26692
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49. |
PMid:33538338 |
2. Yang Z, Yan G, Zheng L, Gu W, Liu F, Chen W, et al. YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration. Oncoimmunology. 2021;10:1938890. |
PMid:34221701 PMCid:PMC8224202 |
3. Krishna A, Singh S, Kumar V, Pal US. Molecular concept in human oral cancer. Natl J Maxillofac Surg. 2015;6:9-15. |
PMid:26668446 PMCid:PMC4668742 |
4. Bugshan A, Farooq I. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Res. 2020;9:229. |
PMid:32399208 PMCid:PMC7194458 |
5. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14:342-57. |
PMid:24705652 |
6. Alipour S, Hadji M, Hosseini L, Omranipour R, Saberi A, Seifollahi A, et al. N Levels of serum 25-hydroxy-vitamin D in benign and malignant breast masses. Asian Pac J Cancer Prev. 2014;15:129-32. |
PMid:24528013 |
7. Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M, et al. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother.2019;109:391-401. |
PMid:30399574 |
8. Peña-Oyarzún D, Guzmán C, Kretschmar C, Torres VA, Maturana-Ramirez A, Aitken J, et al. Calcitriol Treatment Decreases Cell Migration, Viability and β-Catenin Signaling in Oral Dysplasia. Curr Issues Mol Biol. 2024;46:3050-62. |
PMid:38666921 PMCid:PMC11049246 |
9. Osafi J, Hejazi A, Stutz DD, Keiserman MA, Bergman CJ, Kingsley K. Differential effects of 1,25-dihydroxyvitamin D₃ on oral squamous cell carcinomas in vitro. J Diet Suppl. 2014;11:145-54. |
PMid:24670118 |
10. Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem. 2013;59:771-80. |
PMid:23503722 |
11. Gangane N, Chawla S, Anshu, Gupta SS, Sharma SM. Reassessment of risk factors for oral cancer. Asian Pac J Cancer Prev. 2007;8:243-48. |
PMid:17696739 |
12. El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017;66:10-2. |
PMid:28583885 |
13. Domján A, Kakuk P, Sándor J. 50 éves a Helsinki Nyilatkozat: kommentár a 2013-as módosításhoz [The Helsinki Declaration at 50 years: comments on the 2013 modifications]. Lege Artis Med. 2014;24:152-8. |
PMid:25137984 |
14. Hanioka T, Ojima M, Tanaka K, Aoyama H. Relationship between smoking status and tooth loss: Findings from national data- bases in Japan. J Epidemiol. 2007;17:125-32. |
PMid:17641448 PMCid:PMC7058469 |
15. Ferreira Antunes JL, Toporcov TN, Biazevic MG, Boing AF, Scully C, Petti S. Joint and independent effects of alcohol drinking and tobacco smoking on oral cancer: a large case-control study. PloS One. 2013;8:e68132. |
PMid:23874521 PMCid:PMC3707956 |
16. Rojas-Alcayaga G, Brignardello R, Espinoza I, Franco ME, Lobos N, Ortega-Pinto AV. Oral malignant tumours: a report on 728 cases in Chile. Acta Odontol Latinoam. 2010;23:136-42. |
PMid:21053687 |
17. Samanta I, Patil DJ, More CB. Assessment of vitamin D levels in patients with oral potentially malignant disorders and oral squamous cell carcinoma-A cross-sectional study. J Oral Biol Craniofac Res. 2024;14:27-32. |
PMid:38130424 PMCid:PMC10733696 |
18. Udeabor SE, Albejadi AM, Al-Shehri WAK, Onwuka CI, Al-Fathani SY, Al Nazeh AA, et al. Serum levels of 25-hydroxy-vitamin D in patients with oral squamous cell carcinoma: Making a case for chemoprevention. Clin Exp Dent Res. 2020;6:428-32. |
PMid:32246747 PMCid:PMC7453769 |
19. Grimm M, Cetindis M, Biegner T, Lehman M, Munz A, Teriete P, et al. Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC. Med Oral Patol Oral Cir Bucal. 2015;20:e188-95. |
PMid:25662556 PMCid:PMC4393981 |
20. Zhang H, Lu H, Shrestha C, Feng Y, Li Y, Peng J, et al. In serum, higher parathyroid hormone but not lower vitamin D is associated with oral squamous cell carcinoma. Curr Oncol. 2015;22:e259-63. |
PMid:26300676 PMCid:PMC4530823 |
21. Fanidi A, Muller DC, Midttun Ø, Ueland PM, Vollset SE, Relton C, et al. Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci Rep. 2016;6:36017. |
PMid:27812016 PMCid:PMC5095706 |
22. Lipworth L, Rossi M, McLaughlin JK, Negri E, Talamini R, Levi F, et al. Dietary vitamin D and cancers of the oral cavity and esophagus. Ann Oncol.2009;20:1576-81. |
PMid:19487490 |
23. Dudding T, Johansson M, Thomas SJ, Brennan P, Martin RM, Timpson NJ. Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization. Int J Cancer. 2018;143:1029-36. |
PMid:29536507 PMCid:PMC6099266 |
24. Pu Y, Zhu G, Xu Y, Zheng S, Tang B, Huang H, et al. Association Between Vitamin D Exposure and Head and Neck Cancer: A Systematic Review with Meta-Analysis. Front Immunol. 2021;12:627226. |
PMid:33732250 PMCid:PMC7959800 |
25. Anand A, Singh S, Sonkar AA, Husain N, Singh KR, Singh S, et al. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol (Pozn). 2017;21:145-51. |
PMid:28947884 PMCid:PMC5611504 |
26. Maturana-Ramírez A, Aitken-Saavedra J, Guevara-Benítez AL, Espinoza-Santander I. Hypovitaminosis D, oral potentially malignant disorders, and oral squamous cell carcinoma: a systematic review. Med Oral Patol Oral Cir Bucal. 2022;27:e135-e41. |
PMid:35218642 PMCid:PMC8898584 |
27. Giustina A, Bouillon R, Dawson-Hughes B, Ebeling PR, Lazaretti-Castro M, Lips P, et al. Vitamin D in the older population: a consensus statement. Endocrine. 2023;79:31-44. |
PMid:36287374 PMCid:PMC9607753 |
28. Yang L, Zhao H, Liu K, Wang Y, Liu Q, Sun T, et al. Smoking behavior and circulating vitamin D levels in adults: A meta-analysis. Food Sci Nutr. 2021;9:5820-32. |
PMid:34646549 PMCid:PMC8497833 |
29. Gwenzi T, Zhu A, Schrotz-King P, Schöttker B, Hoffmeister M, Brenner H. Effects of vitamin D supplementation on inflammatory response in patients with cancer and precancerous lesions: Systematic review and meta-analysis of randomized trials. Clin Nutr. 2023;42:1142-50. |
PMid:37244755 |
30. Khamis A, Salzer L, Schiegnitz E, Stauber RH, Gül D. The Magic Triangle in Oral Potentially Malignant Disorders: Vitamin D, Vitamin D Receptor, and Malignancy. Int J Mol Sci. 2023;24:15058. |
PMid:37894739 PMCid:PMC10606220 |